항정신병약물 클로자핀이 흰쥐 뇌실로 주입한 인슐린의 반응에 미치는 영향

키워드

참고문헌 (42)

1. Newcomer JW, "Metabolic considerations in the use of antipsychotic medications: a review of recent evidence", J Clin Psychiatry, 68(Suppl 1), pp.20~27 (2007)
2. Henderson DC, "Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study", Am J Psychiatry, 157, pp.975~981 (2000)
3. Henderson DC, "Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis", J Clin Psychiatry, 67, pp.789~797 (2006)
4. Henderson DC, "Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study", J Clin Psychiatry, 66, pp.1116~1121 (2005)
5. Sernyak MJ, "Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia", Am J Psychiatry, 159, pp.561~566 (2002)
6. Houseknecht KL, "Acute effects of atypical antipsychotics on wholebody insulin resistance in rats: implications for adverse metabolic effects", Neuropsychopharmacology, 32, pp.289~297 (2007)
7. Nasrallah HA, "Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles", Mol Psychiatry, 13, pp.27~35 (2008)
8. American Diabetes Association, "Consensus development conference on antipsychotic drugs and obesity and diabetes", Diabetes Care, 27, pp.596~601 (2004)
9. Kim SH, "Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents", J Psychiatr Res, 44, pp.493~498 (2010)
10. Hou JC, "Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking", Curr Opin Cell Biol, 19, pp.466~473 (2007)
11. Ardizzone TD, "Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine", Brain Res, 923, pp.82~90 (2001)
12. Panariello F, "Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped", Pea-15 protein abundance, 2012, pp.227, 1485~1492
13. Dwyer DS, "Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells", Prog Neuropsychopharmacol Biol Psychiatry, 23, pp.69~80 (1999)
14. Hill JW, "Hypothalamic pathways linking energy balance and reproduction", Am J Physiol Endocrinol Metab, 294, pp.E827~E832 (2008)
15. Levin BE, "Metabolic sensing and the brain: who, what, where, and how?", Endocrinology, 152, pp.2552~2557 (2011)
16. Routh VH, "Glucose sensing neurons in the ventromedial hypothalamus", Sensors (Basel), 10, pp.9002~9025 (2010)
17. Tulipano G, "Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation", Neuroendocrinology, 85, pp.61~70 (2007)
18. Martins PJ, "Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance", Diabetes, 59, pp.2418~2425 (2010)
19. García-San Frutos M, "Impaired central insulin response in aged Wistar rats: role of adiposity", Endocrinology, 148, pp.5238~5247 (2007)
20. Kim SH, "Dosedependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1", 2-ERK1, Prog Neuropsychopharmacol Biol Psychiatry, pp.2008, 32[DOI]
21. Yu HS, "Intracerebroventricular administration of ouabain, a Na", K-ATPase inhibitor, activates tyrosine hydroxylase through extracellular signal-regulated kinase in rat striatum, 2011, pp.59(6), 779~786[DOI]
22. Niswender KD, "Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia", Diabetes, 52, pp.227~231 (2003)
23. Gerozissis K, "Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies", Eur J Pharmacol, 585, pp.38~49 (2008)
24. Kalra SP, "Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?", Gene Ther, 18, pp.319~325 (2011)
25. Prodi E, "Minireview: the brain as a molecular target for diabetic therapy", Endocrinology, 147, pp.2664~2669 (2006)
26. Sánchez-Lasheras C, "Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators", Front Neuroendocrinol, 31, pp.14~15 (2010)
27. Cone RD, "The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis", Int J Obes Relat Metab Disord, 25(Suppl 5), pp.S63~S67 (2001)
28. Lin JY, "Effects of various neuroactive substances on single-unit activities of hypothalamic arcuate neurons in brain slices", Brain Res Bull, 31, pp.587~594 (1993)
29. Boura-Halfon S, "Phosphorylation of IRS proteins, insulin action, and insulin resistance", Am J Physiol Endocrinol Metab, 296, pp.E581~E591 (2009)
30. Aubry JM, "Early effects of mood stabilizers on the Akt", GSK-3beta signaling pathway and on cell survival and proliferation, 2009, pp.205, 419~429
31. Kang UG, "The effects of clozapine on the GSK-3-mediated signaling pathway", FEBS LETTERS, 560, pp.115~119 (2004), ELSEVIER SCIENCE BV
32. Lu XH, "Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K", AKT, ERK, and pertussis toxin-sensitive pathways, 2005, pp.27, 43~64
33. Olianas MC, "Regulation of PI3K", Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor, 2011, pp.660, 341~350
34. Myoung-Sun Roh, "Haloperidol and clozapine differentially regulate signalsupstream of glycogen synthase kinase 3 in the rat frontal cortex", Experimental and Molecular Medicine, 39(3), pp.353~360 (2007), 생화학분자생물학회
35. Kim SF, "From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase", Proc Natl Acad Sci U S A, 104, pp.3456~3459 (2007)
36. Boyda HN, "Preclinical models of antipsychotic drug-induced metabolic side effects", Trends Pharmacol Sci, 31, pp.484~497 (2010)
37. Boyda HN, "A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.945~954 (2010)
38. Murashita M, "Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats", Psychoneuroendocrinology, 32, pp.777~784 (2007)
39. Girgis RR, "Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway", Mol Psychiatry, 13, pp.918~929 (2008)
40. Citrome L, "Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement", Diabetes Care, 27, pp.2087~2090 (2004)
41. Jin H, "Atypical antipsychotics and glucose dysregulation: a systematic review", Schizophr Res, 71, pp.195~212 (2004)
42. Mukherjee S, "Family history of type 2 diabetes in schizophrenic patients", Lancet, 1, pp.495~ (1989)

관련 논문AI추천